Safety Assessment of Trimellitic Anhydride Copolymers as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
Historique:
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 29 7 2021
Statut: ppublish

Résumé

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 6 trimellitic anhydride copolymers as used in cosmetics. These ingredients are related as copolymers in that they all share trimellitic anhydride (ie, 1,2,4-benzenetricarboxylic acid anhydride) as a monomer, are reported to function as film formers in cosmetics, and are reported to be primarily used in nail products. Very limited safety data were available or submitted. The Panel concluded that Adipic Acid/Neopentyl Glycol/Trimellitic Anhydride Copolymer and Phthalic Anhydride/Trimellitic Anhydride/Glycols Copolymer are safe in nail product formulations in the present practices of use and concentration, but the data are insufficient to make a determination of safety on the use of these 2 ingredients in all other types of cosmetic formulations. The Panel also concluded that the available data are insufficient to make a determination that the remaining trimellitic anhydride copolymers are safe for use in cosmetic formulations.

Identifiants

pubmed: 33203270
doi: 10.1177/1091581820958690
doi:

Substances chimiques

Cosmetics 0
Phthalic Anhydrides 0
trimellitic anhydride 80T61EUU7H

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

74S-92S

Auteurs

Monice M Fiume (MM)

*44002Cosmetic Ingredient Review Senior Director.

Wilma F Bergfeld (WF)

**Expert Panel for Cosmetic Ingredient Safety Member.

Donald V Belsito (DV)

**Expert Panel for Cosmetic Ingredient Safety Member.

Ronald A Hill (RA)

**Expert Panel for Cosmetic Ingredient Safety Member.

Curtis D Klaassen (CD)

**Expert Panel for Cosmetic Ingredient Safety Member.

Daniel C Liebler (DC)

**Expert Panel for Cosmetic Ingredient Safety Member.

James G Marks (JG)

**Expert Panel for Cosmetic Ingredient Safety Member.

Ronald C Shank (RC)

**Expert Panel for Cosmetic Ingredient Safety Member.

Thomas J Slaga (TJ)

**Expert Panel for Cosmetic Ingredient Safety Member.

Paul W Snyder (PW)

**Expert Panel for Cosmetic Ingredient Safety Member.

Lillian J Gill (LJ)

***44002Cosmetic Ingredient Review Former Director.

Bart Heldreth (B)

†44002Cosmetic Ingredient Review Executive Director.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH